Test Bank For Karch's Focus on Nursing Pharmacology 9TH Edition

Test Bank For Karch's Focus on Nursing Pharmacology 9TH Edition by Rebecca Tucker All Chapters (1-56) A+ ULTIMATE GUIDE 2024 / Cancer Pharm Test 3, Chapter 102, Pharm Final Exam Bank 3/3, Chapter 84, Chapter 85, Lehne 9th Edition Chapter 86: Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others, Pharmacology, Chapter 87: Aminoglycosides: Bacte The nurse wants to evaluate a nursing student's understanding of chemotherapy. The nurse asks, "Which factor would be a major obstacle to successful chemotherapy?" What is the student's best response? a."The patient's reluctance about the doses administered." b."The patient's degree of nausea." c."The toxicity of anticancer drugs to normal tissues." d."The difficulty attaining and maintaining venous access. - ANS-c."The toxicity of anticancer drugs to normal tissues." A nurse is teaching a group of nursing students about cancer treatment. Which statement by a student indicates an understanding of the characteristics of cancer cells? a."Cancer cells are characterized by unrestrained growth and division." b."Division of cancer cells is characteristically rapid." c."Malignant cells of solid tumors do not invade other tissues." d."Telomerase is an enzyme produced by cancer cells that promotes metastases." - ANS-a."Cancer cells are characterized by unrestrained growth and division." A patient is receiving chemotherapy. Seven days after a dose, the patient's neutrophil count is 1000 cells/mm3. The nurse will tell this patient: hospitalization is necessary to provide infection prophylaxis. the provider will probably repeat the lab work in 3 to 5 days. ask the provider about skipping the next dose of chemotherapy. report any symptoms such as pus, abscesses, or cough. - ANS- the provider will probably repeat the lab work in 3 to 5 days. A patient with cancer has a tumor composed mostly of G0 cells. When teaching this patient about the disease, the nurse will make which statement? a."Cells in this patient's type of tumor will proliferate rapidly." b."Chemotherapeutic agents that are not toxic to other tissues may be used." c."This type of tumor is especially sensitive to chemotherapy." d."This tumor will be managed primarily with surgery." - ANS-d."This tumor will be managed primarily with surgery." A nurse is teaching a group of nursing students about how cytotoxic anticancer drugs affect normal cells. Which statement by a student indicates an understanding of this teaching? a."Cytotoxic drugs lack tissue specificity." b."Cytotoxic drugs have a high degree of selective toxicity." c."Differences between cancer cells and normal cells are qualitative." d."Neoplastic cells and normal tissue cells are very different." - ANS-a."Cytotoxic drugs lack tissue specificity." A nurse explains to a patient with cancer why it is difficult to achieve 100% cell kill to cure cancer with chemotherapy. Which statement by the patient indicates a need for further teaching? a."It is necessary to continue giving the same dose of chemotherapeutic agents throughout therapy, even if toxicity occurs." b."Symptoms of cancer often disappear before all malignant cells are eradicated." c."The immune system attacks chemotherapeutic agents and renders them impotent." d."The immune system often fails to recognize cancer cells as foreign." - ANS-c."The immune system attacks chemotherapeutic agents and renders them impotent." These patients are receiving chemotherapy. Which patient should the nurse see first? a.The patient with lightly bleeding gums b.The patient with nausea and vomiting c.The patient with a fever of 100.3°F d.The patient with diarrhea and stomatitis - ANS-c.The patient with a fever of 100.3°F A patient who has undergone surgical removal of a solid tumor has just begun chemotherapy. The patient experiences severe nausea and vomiting as well as alopecia. The nurse will expect the provider to: nue the chemotherapeutic agent at the same dose. ase the dose of chemotherapy to minimize side effects. lab tests to evaluate for the presence of residual cancer cells.